According to Innovent Biologics's latest financial reports the company's current EPS (TTM) is 0,06248ย โฌ. In 2025 the company made an earnings per share (EPS) of 0,06248ย โฌ an increase over its 2024 EPS that were of -0,007486ย โฌ.